Argatroban as a Primary or Secondary Postoperative Anticoagulant in Patients Implanted With Ventricular Assist Devices

Annals of Thoracic Surgery

Volumn 85, Issue 5, 2008, Pages 1651-1655

  Samuels, Louis E ^a   Kohout, Jaromir ^a   Casanova Ghosh, Elena ^a   Hagan, Kevin ^a   Garwood, Phil ^a   Ferdinand, Francis ^a   Goldman, Scott M ^a  

^a LANKENAU HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARGATROBAN; HEPARIN;

ANTICOAGULATION; ARTICLE; ASSISTED CIRCULATION; COMBINATION CHEMOTHERAPY; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART ASSIST DEVICE; HEART FAILURE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MEDICAL RECORD REVIEW; MONOTHERAPY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; THROMBOCYTOPENIA; THROMBOEMBOLISM;

ANTICOAGULANTS; AUTOANTIBODIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HEPARIN; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PARTIAL THROMBOPLASTIN TIME; PIPECOLIC ACIDS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; REPRESSOR PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBIN; THROMBOCYTOPENIA;

EID: 42949123334     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.01.100     Document Type: Article

References (21)

1. Warkentin T.E., and Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 76 (2003) 2121-2131
2. Ohno H., Higashidate M., and Yokosuka T. Argatroban as an alternative anticoagulant for patients with heparin allergy during coronary bypass surgery. Heart Vessels 18 (2003) 40-42
3. Ohteki H., Furukawa K., Ohnishi H., et al. Clinical experience of Argatroban for anticoagulation in cardiovascular surgery. Jpn J Thorac Cardiovasc Surg 48 (2000) 39-46
4. Lee D.H., and Warkentin T.E. Frequency of heparin-induced thrombocytopenia. In: Warkentin T.E., and Greinacher A. (Eds). Heparin-induced thrombocytopenia (2004), Marcel Dekker, New York 107-148
5. Everett B.M., Yeh R., Foo S.Y., et al. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg 83 (2007) 592-597
6. Koster A., Sanger S., Hansen R., et al. Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices. ASAIO J 46 (2000) 319-322
7. Riess F.C. Anticoagulation management and cardiac surgery in patients with heparin-induced thrombocytopenia. Semin Thorac Cardiovasc Surg 17 (2005) 85-96
8. Smith R.E., Townsend G.E., Berry B.R., et al. Enoxaparin for unstable angina and ancrod for cardiac surgery following heparin allergy. Ann Pharmacother 30 (1996) 476-480
9. Fernandes P., Mayer R., MacDonald J.L., et al. Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases. Perfusion 15 (2000) 531-539
10. Silvestry S.C., and Smith P.K. Current status of cardiac surgery in the abciximab-treated patient. Ann Thorac Surg 70 2 Suppl (2000) S12-S19
11. Greinacher A. The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia. Semin Thromb Hemost 30 (2004) 315-327
12. Huebler M., Koster A., Buz S., et al. Cardiopulmonary bypass for complex cardiac surgery using bivalirudin anticoagulation in a patient with heparin antibodies. J Card Surg 21 (2006) 286-288
13. Carr C.S., Rayner A., Ponte J., et al. Off-pump coronary artery bypass grafting in a heparin-induced thrombocytopenia type II patient using hirudin. Ann Thorac Surg 79 (2005) 696-698
14. Lubenow N., Selleng S., Wollert H.G., et al. Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use. Ann Thorac Surg 75 (2003) 577-579
15. Takahama T., Kanai F., Onishi K., et al. Ideal anticoagulation for use with a left ventricular assist device. ASAIO J 41 (1995) M779-M782
16. Takahama T., Kanai F., and Onishi K. Anticoagulation during use of a left ventricular assist device. ASAIO J 46 (2000) 354-357
17. Mejak B., Giacomuzzi C., Heller E., et al. Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia. J Extra Corpor Technol 36 (2004) 178-181
18. Koster A., Buz S., Hetzer, et al. Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: first results form the ARG-E03 trial. J Thorac Cardiovasc Surg 132 (2006) 699-700
19. Gasparovic H., Nathan N.S., Fitzgerald D., et al. Severe argatroban-induced coagulopathy in a patient with a history of heparin-induced thrombocytopenia. Ann Thorac Surg 78 (2004) e89-e91
20. Kurup V., Transue S., Wu Y., et al. Cardiac surgery in a patient with heparin-induced thrombocytopenia-cautions with use of the direct thrombin inhibitor, argatroban. Conn Med 70 (2006) 245-250
21. Cannon M.A., Butterworth J., Riley R.D., et al. Failure of argatroban anticoagulation during off-pump coronary artery bypass surgery. Ann Thorac Surg 77 (2004) 711-713